These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9193313)

  • 41. Reversibility of vigabratin-induced visual-field defect.
    Versino M; Veggiotti P
    Lancet; 1999 Aug; 354(9177):486. PubMed ID: 10465180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Visual field defects due to antiepileptic drugs].
    Stefan H; Bernatik J; Knorr J
    Nervenarzt; 1999 Jun; 70(6):552-5. PubMed ID: 10412701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study.
    Schmitz B; Schmidt T; Jokiel B; Pfeiffer S; Tiel-Wilck K; Rüther K
    J Neurol; 2002 Apr; 249(4):469-75. PubMed ID: 11967655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Guideline may help in prescribing vigabatrin.
    Appleton RE
    BMJ; 1998 Nov; 317(7168):1322. PubMed ID: 9804738
    [No Abstract]   [Full Text] [Related]  

  • 45. Visual field severity indices demonstrate dose-dependent visual loss from vigabatrin therapy.
    Conway M; Cubbidge RP; Hosking SL
    Epilepsia; 2008 Jan; 49(1):108-16. PubMed ID: 18184224
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Study of visual field and vigabatrin treatment in children].
    Pelosse B; Momtchilova M; Roubergue A; Doummar D; Billette de Villemeur T; Laroche L
    J Fr Ophtalmol; 2001 Dec; 24(10):1075-80. PubMed ID: 11913238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer.
    Wild JM; Robson CR; Jones AL; Cunliffe IA; Smith PE
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):917-24. PubMed ID: 16505024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ophthalmologic and neurologic findings in two children exposed to vigabatrin in utero.
    Sorri I; Herrgård E; Viinikainen K; Pääkkönen A; Heinonen S; Kälviäinen R
    Epilepsy Res; 2005 Jun; 65(1-2):117-20. PubMed ID: 15941649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Visual impairment in children with epilepsy treated with vigabatrin.
    Gross-Tsur V; Banin E; Shahar E; Shalev RS; Lahat E
    Ann Neurol; 2000 Jul; 48(1):60-4. PubMed ID: 10894216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Study is needed of visual field defects associated with any long term antiepileptic drug.
    Rao GP; Fat FA; Kyle G; Leach JP; Chadwick DW; Batterbury M
    BMJ; 1998 Jul; 317(7152):206. PubMed ID: 9665915
    [No Abstract]   [Full Text] [Related]  

  • 51. [Subsequent manic disorder due to combination vigabatrin-clomipramine].
    Sastre-Garau P; Thomas P; Beaussart M; Goudemand M
    Encephale; 1994; 20(3):363. PubMed ID: 8088239
    [No Abstract]   [Full Text] [Related]  

  • 52. Visual field defects with vigabatrin: epidemiology and therapeutic implications.
    Kälviäinen R; Nousiainen I
    CNS Drugs; 2001; 15(3):217-30. PubMed ID: 11463129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Visual field constriction associated with vigabatrin: retinal nerve fiber layer photographic correlation.
    Choi HJ; Kim DM
    J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1395. PubMed ID: 15377683
    [No Abstract]   [Full Text] [Related]  

  • 54. Outer retinal dysfunction in patients treated with vigabatrin.
    Arndt CF; Derambure P; Defoort-Dhellemmes S; Hache JC
    Neurology; 1999 Apr; 52(6):1201-5. PubMed ID: 10214744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tangent screens are still useful in the assessment of vigabatrin induced visual field defects.
    Olson JA; Purdie AT; Coleman RJ
    Br J Ophthalmol; 2002 Aug; 86(8):931-2. PubMed ID: 12140220
    [No Abstract]   [Full Text] [Related]  

  • 56. Visual field constriction in children treated with vigabatrin.
    Vanhatalo S; Pääkkönen L; Nousiainen I
    Neurology; 1999 May; 52(8):1713-4. PubMed ID: 10331710
    [No Abstract]   [Full Text] [Related]  

  • 57. Visual field defect associated with vigabatrin: observational cohort study.
    Wilton LV; Stephens MD; Mann RD
    BMJ; 1999 Oct; 319(7218):1165-6. PubMed ID: 10541505
    [No Abstract]   [Full Text] [Related]  

  • 58. Aberrant mTOR signaling and disrupted autophagy: The missing link in potential vigabatrin-associated ocular toxicity?
    Vogel KR; Ainslie GR; Pearl PL; Gibson KM
    Clin Pharmacol Ther; 2017 Apr; 101(4):458-461. PubMed ID: 27864823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vigabatrin and psychosis: is there a true correlation?
    Veggiotti P; De Agostini G; Baldi PL; Muzio C; Lanzi G
    Acta Neurol Scand; 1997 Mar; 95(3):189-90. PubMed ID: 9088390
    [No Abstract]   [Full Text] [Related]  

  • 60. Rapid aggravation of aphasia by vigabatrin.
    Gil R; Neau JP
    J Neurol; 1995 Mar; 242(4):251-2. PubMed ID: 7798126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.